288 related articles for article (PubMed ID: 36230504)
21. VEGF and pleiotrophin modulate the immune profile of breast cancer.
Lynn KD; Roland CL; Brekken RA
Cancers (Basel); 2010 May; 2(2):970-88. PubMed ID: 24281102
[TBL] [Abstract][Full Text] [Related]
22. The reciprocal function and regulation of tumor vessels and immune cells offers new therapeutic opportunities in cancer.
Missiaen R; Mazzone M; Bergers G
Semin Cancer Biol; 2018 Oct; 52(Pt 2):107-116. PubMed ID: 29935312
[TBL] [Abstract][Full Text] [Related]
23. A bladder cancer microenvironment simulation system based on a microfluidic co-culture model.
Liu PF; Cao YW; Zhang SD; Zhao Y; Liu XG; Shi HQ; Hu KY; Zhu GQ; Ma B; Niu HT
Oncotarget; 2015 Nov; 6(35):37695-705. PubMed ID: 26462177
[TBL] [Abstract][Full Text] [Related]
24. Advances in 3D Vascularized Tumor-on-a-Chip Technology.
Jung S; Jo H; Hyung S; Jeon NL
Adv Exp Med Biol; 2022; 1379():231-256. PubMed ID: 35760994
[TBL] [Abstract][Full Text] [Related]
25. 3D tumor angiogenesis models: recent advances and challenges.
Bhat SM; Badiger VA; Vasishta S; Chakraborty J; Prasad S; Ghosh S; Joshi MB
J Cancer Res Clin Oncol; 2021 Dec; 147(12):3477-3494. PubMed ID: 34613483
[TBL] [Abstract][Full Text] [Related]
26. Expression and clinical implication of cyclooxygenase-2 and E-cadherin in oral squamous cell carcinomas.
Santoro A; Bufo P; Russo G; Cagiano S; Papagerakis S; Bucci P; Aquino G; Longo F; Feola A; Giordano A; Di Carlo A; Di Domenico M; Pannone G
Cancer Biol Ther; 2020 Aug; 21(8):667-674. PubMed ID: 26218314
[TBL] [Abstract][Full Text] [Related]
27. Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment.
Zhang J; Tavakoli H; Ma L; Li X; Han L; Li X
Adv Drug Deliv Rev; 2022 Aug; 187():114365. PubMed ID: 35667465
[TBL] [Abstract][Full Text] [Related]
28. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
Shinkaruk S; Bayle M; Laïn G; Déléris G
Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
[TBL] [Abstract][Full Text] [Related]
29. Transforming Growth Factor-β Signaling Plays a Pivotal Role in the Interplay Between Osteosarcoma Cells and Their Microenvironment.
Verrecchia F; Rédini F
Front Oncol; 2018; 8():133. PubMed ID: 29761075
[TBL] [Abstract][Full Text] [Related]
30. Tissue-engineered microenvironment systems for modeling human vasculature.
Tourovskaia A; Fauver M; Kramer G; Simonson S; Neumann T
Exp Biol Med (Maywood); 2014 Sep; 239(9):1264-71. PubMed ID: 25030480
[TBL] [Abstract][Full Text] [Related]
31. Targeting the tumor microenvironment for cancer therapy.
Sounni NE; Noel A
Clin Chem; 2013 Jan; 59(1):85-93. PubMed ID: 23193058
[TBL] [Abstract][Full Text] [Related]
32. Pathophysiology of tumor angiogenesis and its relevance in renal cell cancer.
Strohmeyer D
Anticancer Res; 1999; 19(2C):1557-61. PubMed ID: 10365145
[TBL] [Abstract][Full Text] [Related]
33. Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance.
Liu J; Li P; Wang L; Li M; Ge Z; Noordam L; Lieshout R; Verstegen MMA; Ma B; Su J; Yang Q; Zhang R; Zhou G; Carrascosa LC; Sprengers D; IJzermans JNM; Smits R; Kwekkeboom J; van der Laan LJW; Peppelenbosch MP; Pan Q; Cao W
Cell Mol Gastroenterol Hepatol; 2021; 11(2):407-431. PubMed ID: 32932015
[TBL] [Abstract][Full Text] [Related]
34. The tumor microenvironment.
Anderson NM; Simon MC
Curr Biol; 2020 Aug; 30(16):R921-R925. PubMed ID: 32810447
[TBL] [Abstract][Full Text] [Related]
35. Modelling cancer in microfluidic human organs-on-chips.
Sontheimer-Phelps A; Hassell BA; Ingber DE
Nat Rev Cancer; 2019 Feb; 19(2):65-81. PubMed ID: 30647431
[TBL] [Abstract][Full Text] [Related]
36. Flow shear stress regulates endothelial barrier function and expression of angiogenic factors in a 3D microfluidic tumor vascular model.
Buchanan CF; Verbridge SS; Vlachos PP; Rylander MN
Cell Adh Migr; 2014; 8(5):517-24. PubMed ID: 25482628
[TBL] [Abstract][Full Text] [Related]
37. Enabling peristalsis of human colon tumor organoids on microfluidic chips.
Fang G; Lu H; Al-Nakashli R; Chapman R; Zhang Y; Ju LA; Lin G; Stenzel MH; Jin D
Biofabrication; 2021 Oct; 14(1):. PubMed ID: 34638112
[TBL] [Abstract][Full Text] [Related]
38. III. Angiogenesis: complexity of tumor vasculature and microenvironment.
Furuya M; Yonemitsu Y; Aoki I
Curr Pharm Des; 2009; 15(16):1854-67. PubMed ID: 19519428
[TBL] [Abstract][Full Text] [Related]
39. Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold.
Hu LF; Yang X; Lan HR; Fang XL; Chen XY; Jin KT
Exp Cell Res; 2021 Nov; 408(2):112858. PubMed ID: 34600901
[TBL] [Abstract][Full Text] [Related]
40. Testicular organoids: a new model to study the testicular microenvironment in vitro?
Alves-Lopes JP; Stukenborg JB
Hum Reprod Update; 2018 Mar; 24(2):176-191. PubMed ID: 29281008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
